INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $281,000 | -21.7% | 17,258 | -21.7% | 0.04% | -15.6% |
| Q4 2021 | $359,000 | -69.4% | 22,035 | -72.2% | 0.04% | -62.5% |
| Q3 2021 | $1,175,000 | +145.8% | 79,145 | +999.4% | 0.12% | +84.6% |
| Q3 2019 | $478,000 | -34.6% | 7,199 | -42.8% | 0.06% | +30.0% |
| Q3 2017 | $731,000 | +3.4% | 12,596 | +195.3% | 0.05% | +42.9% |
| Q3 2015 | $707,000 | +173.0% | 4,265 | +296.7% | 0.04% | +250.0% |
| Q2 2015 | $259,000 | -94.4% | 1,075 | -94.5% | 0.01% | -95.9% |
| Q3 2014 | $4,595,000 | +437.4% | 19,412 | +437.0% | 0.24% | +520.5% |
| Q2 2014 | $855,000 | -26.6% | 3,615 | +2.3% | 0.04% | -53.0% |
| Q1 2014 | $1,165,000 | – | 3,534 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |